Skip to main content
Top
Published in: Drugs 1/2024

18-12-2023 | Human Papillomavirus | Letter to the Editor

Comment on “Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study”

Authors: Wen-Bin Yeh, Wei-Kai Lee, Hui-Yuan Chen, Su-Boon Yong, Cheuk-Kwan Sun

Published in: Drugs | Issue 1/2024

Login to get access

Excerpt

Dear Editors …
Literature
1.
go back to reference Chen TY, Wang SI, Hung YM et al. Recent human papillomavirus vaccination is associated with a lower risk of COVID-19: a US database cohort study. Drugs. 2023;83(7):621–32.CrossRefPubMedPubMedCentral Chen TY, Wang SI, Hung YM et al. Recent human papillomavirus vaccination is associated with a lower risk of COVID-19: a US database cohort study. Drugs. 2023;83(7):621–32.CrossRefPubMedPubMedCentral
2.
go back to reference Taquet M, Sillett R, Zhu L et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry. 2022;9(10):815–27.CrossRefPubMedPubMedCentral Taquet M, Sillett R, Zhu L et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry. 2022;9(10):815–27.CrossRefPubMedPubMedCentral
3.
go back to reference Tong Q, Du Y, Cui R et al. Risk of erectile dysfunction in male patients with gout treated with febuxostat or allopurinol: a propensity score-matched cohort study. Drugs. 2022;82(18):1717–26.CrossRefPubMed Tong Q, Du Y, Cui R et al. Risk of erectile dysfunction in male patients with gout treated with febuxostat or allopurinol: a propensity score-matched cohort study. Drugs. 2022;82(18):1717–26.CrossRefPubMed
4.
go back to reference Chang R, Yen-Ting Chen T, Wang SI et al. Risk of autoimmune diseases in patients with COVID-19: a retrospective cohort study. EClinicalMedicine. 2023;56: 101783.CrossRefPubMedPubMedCentral Chang R, Yen-Ting Chen T, Wang SI et al. Risk of autoimmune diseases in patients with COVID-19: a retrospective cohort study. EClinicalMedicine. 2023;56: 101783.CrossRefPubMedPubMedCentral
5.
go back to reference Collins R, Bowman L, Landray M et al. The magic of randomization versus the myth of real-world evidence. N Engl J Med. 2020;382(7):674–8.CrossRefPubMed Collins R, Bowman L, Landray M et al. The magic of randomization versus the myth of real-world evidence. N Engl J Med. 2020;382(7):674–8.CrossRefPubMed
6.
go back to reference Wan EYF, Yan VKC, Mok AHY et al. Effectiveness of molnupiravir and nirmatrelvir-ritonavir in hospitalized patients with COVID-19: a target trial emulation study. Ann Intern Med. 2023;176(4):505–14.CrossRefPubMed Wan EYF, Yan VKC, Mok AHY et al. Effectiveness of molnupiravir and nirmatrelvir-ritonavir in hospitalized patients with COVID-19: a target trial emulation study. Ann Intern Med. 2023;176(4):505–14.CrossRefPubMed
7.
go back to reference Hernán MA, Wang W, Leaf DE. Target trial emulation: a framework for causal inference from observational data. JAMA. 2022;328(24):2446–7.CrossRefPubMed Hernán MA, Wang W, Leaf DE. Target trial emulation: a framework for causal inference from observational data. JAMA. 2022;328(24):2446–7.CrossRefPubMed
Metadata
Title
Comment on “Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study”
Authors
Wen-Bin Yeh
Wei-Kai Lee
Hui-Yuan Chen
Su-Boon Yong
Cheuk-Kwan Sun
Publication date
18-12-2023
Publisher
Springer International Publishing
Published in
Drugs / Issue 1/2024
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.1007/s40265-023-01967-5

Other articles of this Issue 1/2024

Drugs 1/2024 Go to the issue

AdisInsight Report

Vamorolone: First Approval